|
|
|
|
|
|
最高研发阶段批准上市 |
首次获批国家/地区- |
首次获批日期1974-01-01 |
A randomised controlled trial evaluating the safety and efficacy of Flutcasone Propionate Nasal Drops, Nasal Spray and Suspension for Nebulization in post-surgical participants with chronic sinusitis
A Phase 2, Double-Blind, Placebo-Controlled, Multi-Center, Randomized Study Evaluating the Safety and Efficacy of SPRC-AB01, Tobramycin Solution for Nasal Inhalation, in Post-Surgical Subjects With Chronic Sinusitis
The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
100 项与 Naryx Pharma, Inc. 相关的临床结果
0 项与 Naryx Pharma, Inc. 相关的专利(医药)
100 项与 Naryx Pharma, Inc. 相关的药物交易
100 项与 Naryx Pharma, Inc. 相关的转化医学